Dr. Claudia Kemper has been awarded the prestigious Wellcome Trust New Investigator Award. These awards enable exceptional researchers to address the most important questions about health and disease. Dr. Kemper will use the resources given to address the role of complement in the regulation of adaptive Th1-mediated inflammation and autoimmune diseases, such as rheumatoid arthritis and scleroderma. During the course of her Investigator Award she will seek to understand how the autocrine-activated receptor-signalling network regulates Th1-immunity; how dysregulation of these pathways contributes to Th1-driven autoimmunity and how druggable targets in these pathways can be exploited to therapeutically impact arthritis.
The BTCure consortium jointly congratulate Dr Kemper for this prestigious award.